Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 186

1.

Neuro-oncology: Isocitrate dehydrogenase mutations in low-grade gliomas.

Schiff D, Purow BW.

Nat Rev Neurol. 2009 Jun;5(6):303-4. doi: 10.1038/nrneurol.2009.57.

PMID:
19498431
[PubMed - indexed for MEDLINE]
2.

[IDH1/2 mutations in gliomas].

Nobusawa S, Yokoo H.

Brain Nerve. 2011 Dec;63(12):1378-86. Review. Japanese.

PMID:
22147457
[PubMed - indexed for MEDLINE]
3.

Analysis of isocitrate dehydrogenase-1/2 gene mutations in gliomas.

Yu L, Qi ST, Li ZY.

Chin Med J (Engl). 2010 Dec;123(24):3697-705. Review.

PMID:
22166653
[PubMed - indexed for MEDLINE]
Free Article
4.

Isocitrate dehydrogenase mutations: a challenge to traditional views on the genesis and malignant progression of gliomas.

Weller M, Wick W, von Deimling A.

Glia. 2011 Aug;59(8):1200-4. doi: 10.1002/glia.21130. Epub 2011 Feb 3. Review.

PMID:
21294161
[PubMed - indexed for MEDLINE]
5.

Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?

Kloosterhof NK, Bralten LB, Dubbink HJ, French PJ, van den Bent MJ.

Lancet Oncol. 2011 Jan;12(1):83-91. doi: 10.1016/S1470-2045(10)70053-X. Epub 2010 Jul 7. Review.

PMID:
20615753
[PubMed - indexed for MEDLINE]
6.

Significance of IDH mutations varies with tumor histology, grade, and genetics in Japanese glioma patients.

Mukasa A, Takayanagi S, Saito K, Shibahara J, Tabei Y, Furuya K, Ide T, Narita Y, Nishikawa R, Ueki K, Saito N.

Cancer Sci. 2012 Mar;103(3):587-92. doi: 10.1111/j.1349-7006.2011.02175.x. Epub 2012 Jan 13.

PMID:
22136423
[PubMed - indexed for MEDLINE]
7.

Glioma-derived mutations in IDH: from mechanism to potential therapy.

Fu Y, Huang R, Du J, Yang R, An N, Liang A.

Biochem Biophys Res Commun. 2010 Jun 25;397(2):127-30. doi: 10.1016/j.bbrc.2010.05.115. Epub 2010 May 27. Review.

PMID:
20510884
[PubMed - indexed for MEDLINE]
8.

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

Hartmann C, Meyer J, Balss J, Capper D, Mueller W, Christians A, Felsberg J, Wolter M, Mawrin C, Wick W, Weller M, Herold-Mende C, Unterberg A, Jeuken JW, Wesseling P, Reifenberger G, von Deimling A.

Acta Neuropathol. 2009 Oct;118(4):469-74. doi: 10.1007/s00401-009-0561-9. Epub 2009 Jun 25.

PMID:
19554337
[PubMed - indexed for MEDLINE]
9.

[Mutations of IDH1 and 2 genes: a molecular diagnosis of low-grade gliomas].

Larsen CJ.

Bull Cancer. 2009 Jun;96(6):641-2. French. No abstract available.

PMID:
19585679
[PubMed - indexed for MEDLINE]
10.

IDH1 and IDH2 mutations in gliomas.

Cohen AL, Holmen SL, Colman H.

Curr Neurol Neurosci Rep. 2013 May;13(5):345. doi: 10.1007/s11910-013-0345-4. Review.

PMID:
23532369
[PubMed - indexed for MEDLINE]
11.

Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

Sanson M, Marie Y, Paris S, Idbaih A, Laffaire J, Ducray F, El Hallani S, Boisselier B, Mokhtari K, Hoang-Xuan K, Delattre JY.

J Clin Oncol. 2009 Sep 1;27(25):4150-4. doi: 10.1200/JCO.2009.21.9832. Epub 2009 Jul 27.

PMID:
19636000
[PubMed - indexed for MEDLINE]
12.

New insights into glioma classification based on isocitrate dehydrogenase 1 and 2 gene status.

Shibahara I, Sonoda Y, Kanamori M, Saito R, Kumabe T, Tominaga T.

Brain Tumor Pathol. 2011 Jul;28(3):203-8. doi: 10.1007/s10014-011-0050-4. Epub 2011 Jul 7. Review.

PMID:
21735252
[PubMed - indexed for MEDLINE]
13.

Analysis of IDH1 and IDH2 mutations in Japanese glioma patients.

Sonoda Y, Kumabe T, Nakamura T, Saito R, Kanamori M, Yamashita Y, Suzuki H, Tominaga T.

Cancer Sci. 2009 Oct;100(10):1996-8. doi: 10.1111/j.1349-7006.2009.01270.x.

PMID:
19765000
[PubMed - indexed for MEDLINE]
14.

IDH1 and IDH2 mutations in gliomas.

Ducray F, Marie Y, Sanson M.

N Engl J Med. 2009 May 21;360(21):2248-9; author reply 2249. No abstract available.

PMID:
19469031
[PubMed - indexed for MEDLINE]
15.

Molecular pathogenesis of IDH mutations in gliomas.

Ichimura K.

Brain Tumor Pathol. 2012 Jul;29(3):131-9. doi: 10.1007/s10014-012-0090-4. Epub 2012 Mar 8. Review.

PMID:
22399191
[PubMed - indexed for MEDLINE]
16.

IDH mutations in human glioma.

Kim W, Liau LM.

Neurosurg Clin N Am. 2012 Jul;23(3):471-80. doi: 10.1016/j.nec.2012.04.009. Epub 2012 May 31. Review.

PMID:
22748659
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Isocitrate dehydrogenase 1: what it means to the neurosurgeon: a review.

Hodges TR, Choi BD, Bigner DD, Yan H, Sampson JH.

J Neurosurg. 2013 Jun;118(6):1176-80. doi: 10.3171/2013.3.JNS122282. Epub 2013 Apr 12. Review.

PMID:
23581583
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Analysis of the IDH1 codon 132 mutation in brain tumors.

Balss J, Meyer J, Mueller W, Korshunov A, Hartmann C, von Deimling A.

Acta Neuropathol. 2008 Dec;116(6):597-602. doi: 10.1007/s00401-008-0455-2. Epub 2008 Nov 5.

PMID:
18985363
[PubMed - indexed for MEDLINE]
19.

IDH mutations in glioma and acute myeloid leukemia.

Dang L, Jin S, Su SM.

Trends Mol Med. 2010 Sep;16(9):387-97. doi: 10.1016/j.molmed.2010.07.002. Epub 2010 Aug 5. Review.

PMID:
20692206
[PubMed - indexed for MEDLINE]
20.

IDH1 and IDH2 mutations in gliomas.

Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, Bigner DD.

N Engl J Med. 2009 Feb 19;360(8):765-73. doi: 10.1056/NEJMoa0808710.

PMID:
19228619
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk